This role is no longer accepting applications via Rocketlist.
Associate Director, Radiopharmaceutical Development
ARTBIORadiopharmaceutical Oncology company
Cambridge, United StatesDirector
F-Prime Capital
Omega Funds
Radforsk
Third Rock Ventures
Sofinnova Investments
B Capital
About the role
TL;DR
Drive radiopharmaceutical development for Radioligand Therapy products.
- •Drive the radiopharmaceutical development of Radioligand Therapy (RLT) products by designing radiolabeling synthesis, formulation, and process development.
- •Key Responsibilities Lead radiolabeling, formulation, and analytical method development of small molecules and peptides with different chelators and radiometals.
- •Organize, manage, and execute technology transfer to CDMOs.
- •Oversee the technical development of ARTBIO’s products with CDMOs.
- •Requirements PhD in Radiochemistry, Chemical Engineering, Radiopharmaceuticals, or related fields within life sciences.
- •Minimum of 5 years of experience in the radiopharmaceutical field, with a focus on manufacturing and process development.
- •Experience and familiarity with GMP environments and radiopharmaceutical manufacturing processes.
Required skills
Project ManagementCompliance ManagementTechnical Leadership
Nice-to-have skills
Compliance ManagementTechnical Leadership
Domain expertise
healthcare